Population Immunity Against COVID-19 in the United States

被引:16
|
作者
Moghadas, Seyed M. [1 ]
Sah, Pratha [2 ]
Shoukat, Affan [2 ]
Meyers, Lauren Ancel [3 ,4 ]
Galvani, Alison P. [2 ]
机构
[1] York Univ, Agent Based Modelling Lab, 4700 Keele St, Toronto, ON, Canada
[2] Yale Sch Publ Hlth, Yale Ctr Infect Dis Modeling & Anal, 135 Coll St,Suite 200, New Haven, CT 06510 USA
[3] Univ Texas Austin, Dept Integrat Biol, 1 Univ Stn C0990, Austin, TX 78712 USA
[4] Santa Fe Inst, Santa Fe, NM 87501 USA
基金
加拿大自然科学与工程研究理事会; 美国国家卫生研究院; 加拿大健康研究院; 美国国家科学基金会;
关键词
SARS-COV-2;
D O I
10.7326/M21-2721
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: As of 28 July 2021, 60% of adults in the United States had been fully vaccinated against COVID-19, and more than 34 million cases had been reported. Given the uncertainty regarding undocumented infections, the population level of immunity against COVID-19 in the United States remains undetermined. Objective: To estimate the population immunity, defined as the proportion of the population that is protected against SARS-CoV-2 infection due to prior infection or vaccination. Design: Statistical and simulation modeling to estimate overall and age-specific population immunity. Setting: United States. Participants: Simulated age-stratified population representing U.S. demographic characteristics. Measurements: The true number of SARS-CoV-2 infections in the United States was inferred from data on reported deaths using age-specific infection-fatality rates (IFRs). Taking into account the estimates for vaccine effectiveness and protection against reinfection, the overall population immunity was determined as the sum of protection levels in vaccinated persons and those who were previously infected but not vaccinated. Results: Using age-specific IFR estimates from the Centers for Disease Control and Prevention, it was estimated that as of 15 July 2021, 114.9 (95% credible interval [CrI], 103.2 to 127.4) million persons had been infected with SARS-CoV-2 in the United States. The mean overall population immunity was 62.0% (CrI, 58.4% to 66.4%). Adults aged 65 years or older were estimated to have the highest immunity level (77.2% [CrI, 76.2% to 78.6%]), and children younger than 12 years had the lowest immunity level (17.9% [CrI, 14.4% to 21.9%]). Limitation: Publicly reported deaths may underrepresent actual deaths. Conclusion: As of 15 July 2021, the U.S. population immunity against COVID-19 may still have been insufficient to contain the outbreaks and safely revert to prepandemic social behavior. Primary Funding Source: National Science Foundation, National Institutes of Health, Notsew Orm Sands Foundation, Canadian Institutes of Health Research, and Natural Sciences and Engineering Research Council of Canada.
引用
收藏
页码:1586 / +
页数:9
相关论文
共 50 条
  • [41] Modeling the COVID-19 Epidemic With Multi-Population and Control Strategies in the United States
    Sun, Deshun
    Long, Xiaojun
    Liu, Jingxiang
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 9
  • [42] COVID-19 Pandemic: Disparate Health Impact on the Hispanic/Latinx Population in the United States
    Gil, Raul Macias
    Marcelin, Jasmine R.
    Zuniga-Blanco, Brenda
    Marquez, Carina
    Mathew, Trini
    Piggott, Damani A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (10): : 1592 - 1595
  • [43] Space-time clustering of COVID-19 cases in the United States veteran population
    Richard, Danielle M.
    Gazmararian, Julie A.
    Greenhouse, Alyssa
    Khakharia, Anjali
    Phillips, Lawrence S.
    Waller, Lance A.
    [J]. ANNALS OF EPIDEMIOLOGY, 2023, 87 : 9 - 16
  • [44] Population density and basic reproductive number of COVID-19 across United States counties
    Sy, Karla Therese L.
    White, Laura F.
    Nichols, Brooke E.
    [J]. PLOS ONE, 2021, 16 (04):
  • [45] First Case of Covid-19 in the United States Reply
    Uyeki, Timothy M.
    Holshue, Michelle L.
    Diaz, George
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19):
  • [46] Invited commentary: The Covid-19 pandemic in the United States
    Holtzman, Neil A.
    [J]. INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2021, 20 (01)
  • [47] The COVID-19 Pandemic and Export Disruptions in the United States
    Schoeneman, John
    Brienen, Marten
    [J]. COMPLEX NETWORKS & THEIR APPLICATIONS X, VOL 1, 2022, 1015 : 721 - 731
  • [48] The burden of acute pancreatitis on COVID-19 in the United States
    Chaudhry, Hunza
    Sohal, Aalam
    Kohli, Isha
    Dukovic, Dino
    Sharma, Raghav
    Singla, Piyush
    Hu, Bing
    Prajapati, Devang
    Yang, Juliana
    [J]. ANNALS OF GASTROENTEROLOGY, 2023, : 208 - 215
  • [49] COVID-19 as the Leading Cause of Death in the United States
    Woolf, Steven H.
    Chapman, DerekA.
    Lee, Jong Hyung
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (02): : 123 - 124
  • [50] An Uncomplicated Delivery in a Patient with Covid-19 in the United States
    Iqbal, Sara N.
    Overcash, Rachael
    Mokhtari, Neggin
    Saeed, Haleema
    Gold, Stacey
    Auguste, Tamika
    Mirza, Muhammad-Usman
    Ruiz, Maria-Elena
    Chahine, Joeffrey J.
    Waga, Masashi
    Wortmann, Glenn
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16):